Appreciable uncertainty regarding benefits and risks in the treatment of bacterial vaginosis to prevent preterm birth
Acta Obstet Gynecol Scand
.
2017 Feb;96(2):251-252.
doi: 10.1111/aogs.13076.
Authors
Thor Haahr
1
2
,
Anne S Ersbøll
3
,
Mona A Karlsen
3
,
Jens Svare
4
,
Kirstine Sneider
5
,
Lene Hee
6
,
Louise K Weile
7
,
Agnes Ziobrowska-Bech
8
,
Claus Østergaard
9
,
Jørgen S Jensen
2
,
Rikke B Helmig
10
,
Niels Uldbjerg
10
Affiliations
1
The Fertility Clinic, Skive Regional Hospital, Skive, Denmark.
2
Statens Serum Institute, Copenhagen, Denmark.
3
Department of Obstetrics, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
4
Department of Obstetrics and Gynecology, Copenhagen University Hospital Herlev Gentofte, Herlev, Denmark.
5
Department of Obstetrics and Gynecology, Vendsyssel Hospital, Aalborg University, Aalborg, Denmark.
6
Department of Obstetrics and Gynecology, Nordsjaellands Hospital, Hillerød, Denmark.
7
Department of Gynecology and Obstetrics, Odense University Hospital, Odense, Denmark.
8
Department of Clinical Pharmacology, Aarhus University Hospital, Aarhus, Denmark.
9
Department of Clinical Microbiology, Vejle Hospital, Vejle, Denmark.
10
Department of Obstetrics and Gynecology, Aarhus University Hospital, Skejby, Denmark.
PMID:
27935630
DOI:
10.1111/aogs.13076
No abstract available
Publication types
Letter
Comment
MeSH terms
Female
Humans
Infant, Newborn
Obstetric Labor, Premature / prevention & control
Pregnancy Complications, Infectious
Premature Birth*
Risk Assessment
Uncertainty
Vaginosis, Bacterial*